glimepiride and malondialdehyde

glimepiride has been researched along with malondialdehyde in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grzymisławski, M; Koźlik, J; Krauss, H; Mikrut, K; Paluszak, J; Piatek, J; Sosnowski, P1
Diamant, M; Scheffer, PG; Schumm-Draeger, PM; Siegmund, T; von Bibra, H1

Trials

1 trial(s) available for glimepiride and malondialdehyde

ArticleYear
Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease.
    Diabetes & vascular disease research, 2008, Volume: 5, Issue:4

    Topics: Adiponectin; Aged; C-Reactive Protein; Diabetes Mellitus, Type 2; Diastole; Drug Therapy, Combination; Echocardiography, Doppler, Pulsed; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Malondialdehyde; Metformin; Middle Aged; Myocardial Contraction; Myocardium; Oxidative Stress; Pilot Projects; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome

2008

Other Studies

1 other study(ies) available for glimepiride and malondialdehyde

ArticleYear
The influence of glimepiride on the oxidative state of rats with streptozotocin-induced hyperglycemia.
    Medical science monitor : international medical journal of experimental and clinical research, 2003, Volume: 9, Issue:11

    Topics: Animals; Antioxidants; Body Weight; Glutathione; Hyperglycemia; Hypoglycemic Agents; Male; Malondialdehyde; Oxidative Stress; Oxygen; Peroxides; Rats; Rats, Wistar; Streptozocin; Sulfonylurea Compounds

2003